TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ).
GlaxoSmithKline Pharmaceuticals Limited has announced a significant leadership change with Mr. Juby Chandy taking over as Vice President, Finance for the Asia Pacific region effective December 1, 2025. This strategic appointment is expected to enhance the company’s financial leadership across Asia Pacific markets, ensuring continuity as Mr. Chandy will also remain Chief Financial Officer until a successor is appointed.
More about GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products. The company is known for its wide range of medicines and vaccines, catering to various health needs globally.
Average Trading Volume: 2,628
Technical Sentiment Signal: Sell
Current Market Cap: 422B INR
For detailed information about GLAXO stock, go to TipRanks’ Stock Analysis page.